Brief: Viveve Medical - Resubmits U.S. Investigational Device Exemption To FDA To Conduct Pursuit Trial For Improvement Of Stress Urinary Incontinence

Viveve Medical

15/04/2020 14:25

April 15 (Reuters) - Viveve Medical Inc  VIVE.O :
    * VIVEVE MEDICAL INC - RESUBMITS U.S. INVESTIGATIONAL DEVICE
EXEMPTION TO FDA TO CONDUCT PURSUIT TRIAL FOR IMPROVEMENT OF
STRESS URINARY INCONTINENCE
    * VIVEVE MEDICAL - RESUBMITTED IDE TO BEGIN SUI TRIAL
ADDRESSES
PROTOCOL REQUESTS, PROVIDES POSITIVE RESULTS FROM ADDITIONAL IN
VIVO ANIMAL SAFETY
    * VIVEVE MEDICAL INC - SUI FEASIBILITY TRIAL COMPLETED
ENROLLMENT
IN MARCH, AND IS TARGETED FOR READOUT IN LATE SUMMER OF 2020
    * VIVEVE MEDICAL - IF POSITIVE, RESULTS OF SUI FEASIBILITY
TRIAL
COULD SUPPORT LAUNCH OF PIVOTAL PURSUIT TRIAL IN U.S. FOR
IMPROVEMENT OF SUI IN WOMEN

Source text for Eikon: https://bit.ly/2K8oC7a
Further company coverage:  VIVE.O 

 ((Briefs@thomsonreuters.com;))